Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
Acq. announced
Director departure
Appointed director
|
|
ORE PHARMACEUTICAL HOLDINGS INC. (ORXE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/29/2010 |
4
| Steel Partners, Ltd. (10% Owner) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 125,000 shares
@ $0.255, valued at
$31.9k
Bought 68,000 shares
@ $0.255, valued at
$17.3k
|
|
| 01/20/2010 |
4
| Donahue Stephen R (Senior Vice President) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 2,500 options to buy
@ $0.57, valued at
$1.4k
|
|
| 01/20/2010 |
4
| Palleiko Benjamin L (SVP & CFO) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 6,250 options to buy
@ $0.57, valued at
$3.6k
|
|
| 12/02/2009 |
4
| Gabrielson Mark J (CEO) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.62, valued at
$1.2k
|
|
| 12/01/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.55, valued at
$1.1k
|
|
| 11/25/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.575, valued at
$1.2k
Bought 2,000 shares
@ $0.575, valued at
$1.2k
|
|
| 11/23/2009 |
4
| Gabrielson Mark J (CEO) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.62, valued at
$1.2k
Bought 1,980 shares
@ $0.64, valued at
$1.3k
Bought 20 shares
@ $0.62, valued at
$12.4 |
|
| 11/23/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.64, valued at
$1.3k
|
|
| 11/20/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 300 shares
@ $0.6327, valued at
$189.8
Bought 1,700 shares
@ $0.6336, valued at
$1.1k
|
|
| 10/22/2009 |
4
| THOMPSON J STARK PHD (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
| 10/22/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
| 10/22/2009 |
4
| URDAL DAVID (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
| 10/22/2009 |
4
| GORRY G ANTHONY PHD (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
| 08/28/2009 |
4
| Gabrielson Mark J (CEO) has filed a Form 4 on ORE PHARMACEUTICALS INC. |
| 08/19/2009 |
4
| Gabrielson Mark J (CEO) has filed a Form 4 on ORE PHARMACEUTICALS INC. |
| 07/17/2009 |
4
| Palleiko Benjamin L (SVP & CFO) has filed a Form 4 on GENE LOGIC INC |
| 06/11/2009 |
4
| Donahue Stephen R (Senior Vice President) has filed a Form 4 on GENE LOGIC INC |
| 04/15/2009 |
4
| Gabrielson Mark J (Director) has filed a Form 4 on GENE LOGIC INC |
|
|